Press release
United States Controlled Environment Agriculture (CEA) Market to Reach $271.01 Billion by 2032, Expanding at 15.23% CAGR
The Global Controlled Environment Agriculture (CEA) Market is growing quickly due to rising urban populations, decreasing arable land, and the rise of technology-driven sustainable farming. The market, valued at USD 87.19 billion in 2024, is expected to reach USD 271.01 billion by 2032. This growth represents a CAGR of 15.23% during this period. Key factors include year-round cultivation, efficient resource use, and automated systems that use AI and IoT to improve growing conditions. The strongest adoption occurs in leafy greens, herbs, microgreens, tomatoes, and berries, spanning commercial agriculture, urban farming, and community-supported agriculture (CSA).Get a Sample PDF Brochure of the Report (Use Corporate Email ID for Quick Response): https://www.datamintelligence.com/download-sample/controlled-environment-agriculture-market?ram
United States - Industry Developments (2025)
-Vertical farms and greenhouses are expanding; they use AI and IoT to monitor conditions and improve crop yields.
-Public-private partnerships are supporting urban farming efforts and CSA programs.
-USDA programs are introducing crop insurance and subsidies to help manage risks in controlled-environment farming.
-Companies like Hydrofarm Inc. and Gotham Greens are scaling operations with high-tech facilities for reliable year-round production.
Asia-Pacific - Industry Developments (2025)
-Governments in India and Singapore are offering subsidies and incentives for aeroponic and indoor farming.
-Singapore's "30 by 30" initiative aims to meet 30% of local nutritional needs by 2030.
-In South Korea, smart farm technology is attracting younger farmers and modernizing traditional agriculture.
-Pilot projects in KSA and other dry regions are exploring energy-efficient and sustainable CEA systems.
Industry Players:
Leading companies such as Hydrofarm Inc., Illumitex, Virgo Technologies Inc., Heliospectra AB, Green Automation Group Oy, Kryzen Biotech, Agroz Group, Cultiveat, Boom Grow Farms, and Gotham Greens are driving innovation and technology use in CEA systems.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=controlled-environment-agriculture-market?ram
Market Segmentation:
-By Facility Type: Greenhouses, Vertical Farms, Container Farms, Indoor Plant Factories, Others. Greenhouses lead due to their scalability and established setup.
-By Crop: Leafy Greens, Herbs, Microgreens, Tomatoes and Berries, Mushrooms, Others. Leafy greens and microgreens represent the highest adoption.
-By Technique: Hydroponics, Aeroponics, Aquaponics, LED Lighting Systems, IoT and Automation, Others. Hydroponics and IoT techniques promote efficiency.
-By End-User: Commercial Agriculture, Urban Farming, Community-Supported Agriculture (CSA), Others. Commercial agriculture is the main adopter.
-By Region: North America is in the lead with strong infrastructure and supportive policies, followed by Europe and Asia-Pacific, which are growing their urban farming efforts.
Forecast Projection:
The global CEA market is expected to keep growing strongly through 2032. This growth is fueled by technology integration, urban food demand, and sustainability needs. AI, IoT, and automation in greenhouses and vertical farms are improving precision, productivity, and resource efficiency. The increasing demand for high-quality crops year-round in urban areas is further speeding up adoption. This change reduces reliance on traditional farming and supports global food security goals.
Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/controlled-environment-agriculture-market?ram
Market Intelligence Research Process:
This report uses a detailed method that combines primary interviews with industry stakeholders, end-users, and technology providers. It also includes secondary research from government publications, company reports, and academic studies. Data triangulation ensures accurate market sizing and forecasts. Trend analysis, scenario modeling, and insights across facility types, crops, techniques, end-users, and regions offer useful information for strategic planning.
Challenges & Restraints:
-High Energy Consumption: Lighting and climate control can account for up to 28% of operational costs.
-Operational Complexity: Precision monitoring and advanced technology need specialized skills.
-High Capital Investment: The initial setup costs for vertical farms and advanced greenhouses are considerable.
-Regulatory Compliance: Following agricultural, environmental, and food safety rules can delay deployment.
Benefits of the Report:
-Provides useful insights for investment, expansion, and technology use.
-Highlights new trends, regional opportunities, and technological advances.
-Identifies growth potential across facility types, crops, techniques, and end-users.
-Aids strategic decision-making with precise market sizing, forecasts, and competitive insights.
Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organisations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to provide swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customised reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains, creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Controlled Environment Agriculture (CEA) Market to Reach $271.01 Billion by 2032, Expanding at 15.23% CAGR here
News-ID: 4213290 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
Regenerative Agriculture Market to Reach USD 48.14 Billion by 2032 | Cover Cropp …
The Global Regenerative Agriculture Market USD 12,634.54 million in 2024 and is projected to witness lucrative growth by reaching up to USD 48,139.24 million by 2032. The market is growing at a CAGR of 18.20% during the forecast period 2025-2032.
The Regenerative Agriculture Market is rapidly gaining traction as farmers, agribusinesses, and policymakers focus on sustainable practices that restore soil health, enhance biodiversity, and mitigate climate change. Driven by increasing consumer…
United States Neonatal Intensive Care Unit Market 2026 | Growth Drivers, Trends …
Market Size and Growth
Neonatal intensive care unit market is estimated to reach at a CAGR of 4.19% during the forecast period (2024-2031).
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/neonatal-intensive-care-unit-market?sb
Key Development:
United States: Recent Industry Developments
✅ In February 2026, VirtuAlly became one of the first in the nation to integrate experienced virtual registered nurses into a Level IV Neonatal Intensive Care Unit care team,…
Orphan Drugs Market to Surge Beyond USD 350 Billion by 2033 | Biologics, Gene & …
The Global Orphan Drugs Market reached US$ 223.76billion in 2023 and is expected to reach US$ 486.51 billion by 2032, growing at a CAGR of 9.1% during the forecast period 2024-2032.
The Orphan Drugs Market is witnessing rapid growth as pharmaceutical companies and healthcare systems focus on developing treatments for rare and life-threatening diseases that affect small patient populations. Driven by increasing regulatory support, such as orphan drug designations, tax incentives,…
Ophthalmology Drugs Market to Reach USD 73.97 Billion by 2033 | Biologics, Anti- …
The global ophthalmology drugs market reached US$ 42.30 Billion with a rise of US$ 44.58 Billion in 2024 and is expected to reach US$ 73.97 Billion by 2033, growing at a CAGR of 5.8% during the forecast period 2025-2033.
The Ophthalmology Drugs Market is experiencing steady expansion driven by the rising prevalence of vision-related disorders such as glaucoma, dry eye syndrome, retinal diseases, and age-related macular degeneration. Increasing screen exposure, aging…
More Releases for CEA
Carcinoembryonic Antigen (CEA) Market Is Going to Boom |• Roche • Abbott
Worldwide Market Reports has recently published an in-depth research study titled "Carcinoembryonic Antigen (CEA) Market Size and Forecast 2026-2033: Analysis by Manufacturers, Key Regions, Product Types, and Applications." The report is developed using a robust blend of primary and secondary research methodologies, ensuring accuracy, reliability, and comprehensive market coverage. Leveraging historical data and forward-looking projections, the study presents a detailed evaluation of the Carcinoembryonic Antigen (CEA) market growth, analyzing trends…
Carcinoembryonic Antigen (CEA) Market Size, Share | Industry Report 2026
The global Carcinoembryonic Antigen (CEA) Market was valued at $5.3 Billion in 2018 and is forecast to grow at a modest 6.1 % CAGR between 2018 and 2026, culminating in 2026 global sales of $ 9.2 Billion.
Carcinoembryonic AntigenTest is a blood test which identifies the diagnose and manage certain cancer disease like rectum and large intestine. Basically, it is used to check how well treatment is working in certain…
Carcinoembryonic Antigen (CEA) Market Investment Research Report 2017 – 2027
Carcinoembryonic antigen (CEA) is normally found in embryonic entodermal epithelium. Carcinoembryonic antigen is a group of glycoprotein present in the body fluids of the fetus and embryo and in the gastrointestinal tract. Carcinoembryonic antigen is also present in the mucosal cells of the colorectum, gastrointestinal cells, and small amounts are present in the blood. Carcinoembryonic antigen is produced by the gastrointestinal tissues during the development of fetal. CEA is not…
Carcinoembryonic Antigen (CEA) Market foreseen to grow exponentially over 2027
Carcinoembryonic antigen (CEA) is normally found in embryonic entodermal epithelium. Carcinoembryonic antigen is a group of glycoprotein present in the body fluids of the fetus and embryo and in the gastrointestinal tract. Carcinoembryonic antigen is also present in the mucosal cells of the colorectum, gastrointestinal cells, and small amounts are present in the blood. Carcinoembryonic antigen is produced by the gastrointestinal tissues during the development of fetal. CEA is not…
Carcinoembryonic Antigen (CEA) Market to hit $2.7bn by 2023
Carcinoembryonic Antigen (CEA) Market size is driven by increasing incidence rate for cancer disease especially colorectal cancer is one of the important factor contributing to the growth. Global Carcinoembryonic Antigen Market is set to register profitable growth in the near future and surpass USD 2.8 billion by 2023.
This growth is attributed to factors including consistent technology advancements, development of novel biomarkers and growing prevalence of cancer. Global Market Insights,…
CEA Antibodies Market Outlook And Research Survey To 2023
CEA stands for carcinoembryonic antigen, is a protein that is usually produced in developing fetus and disappears or is absent in adults. Production of abnormal amount of CEA protein may lead to cancer. CEA test is performed to measure the level of proteins and check for the recurrence of colon and other cancers in patients already diagnosed with cancer. The normal accepted range of this protein that is non-cancerous in…
